Andrés J.M. Ferreri

Author

Andrés J.M. Ferreri

Also Known As

A FERRERI, A Ferreri, A J M Ferreri, A. Ferreri, A. J. Ferreri, A. J. M Ferreri, A. J. M. Ferreri, A. J.M. Ferreri, A.J Ferreri, A.J. Ferreri

758

Publications

30.4K

Citations

H-Index

125

Concepts

All Affiliations

San Raffaele University of Rome Istituti di Ricovero e Cura a Carattere Scientifico Vita-Salute San Raffaele University Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele University Hospital of Basel

About

Andrés J.M. Ferreri is an author at San Raffaele University of Rome specializing in medicine, oncology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	49	87	7.9K
2	Health Sciences	18	25	2.6K
3	Engineering	5	5	621
4	Biomedical Engineering	1	1	104
5	Biomolecular Engineering	1	1	11

Andrés J.M. Ferreri

210

Publications

20.8K

Citations

H-Index

Page 1

	Year	Citations
Report of an International Workshop to Standardize Baseline Evaluation and Response Criteria for Primary CNS Lymphoma Lauren E. Abrey, Tracy T. Batchelor, Andrés J.M. Ferreri, Journal of Clinical Oncology Pcnsl SurvivorsPrimary Cns LymphomaPathologyGliomaResponse Criteria	2005	882
Prognostic Scoring System for Primary CNS Lymphomas: The International Extranodal Lymphoma Study Group Experience Andrés J.M. Ferreri, Jean‐Yves Blay, Michele Reni, Journal of Clinical Oncology	2003	824
MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program Shimin Hu, Zijun Y. Xu‐Monette, Alexandar Tzankov, Blood	2013	671
Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial Andrés J.M. Ferreri, Kate Cwynarski, Elisa Jacobsen Pulczynski, The Lancet Haematology	2016	582
Evidence for an Association Between Chlamydia psittaci and Ocular Adnexal Lymphomas Andrés J.M. Ferreri, Massimo Guidoboni, Maurilio Ponzoni, JNCI Journal of the National Cancer Institute	2004	552
Tisagenlecleucel in adult relapsed or refractory follicular lymphoma: the phase 2 ELARA trial Nathan Fowler, Michael Dickinson, Martin Dreyling, Nature Medicine Lymphoid NeoplasiaHematologyImmunologyPathologyElara Trial	2021	492
Nongastric marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue Emanuele Zucca, Annarita Conconi, E Pedrinis, Blood	2003	489
Definition, Diagnosis, and Management of Intravascular Large B-Cell Lymphoma: Proposals and Perspectives From an International Consensus Meeting Maurilio Ponzoni, Andrés J.M. Ferreri, Elı́as Campo, Journal of Clinical Oncology Ivlbcl PatientsElderly PatientsImmunologyPathologyHematological Malignancy	2007	482
Patterns of Outcome and Prognostic Factors in Primary Large-Cell Lymphoma of the Testis in a Survey by the International Extranodal Lymphoma Study Group Emanuele Zucca, Annarita Conconi, Tariq I. Mughal, Journal of Clinical Oncology	2002	441
Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP Consortium Program Study Zijun Y. Xu‐Monette, Lin Wu, Carlo Visco, Blood	2012	383

Page 1